LACOSAMIDE
- Product NDC
- 25021-791
- 11-digit product format
- 250210791
- Labeler code
- 25021
- Product ID
- 25021-791_3cabc3ea-4c98-462e-ae04-ccc0ab25c7a7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LACOSAMIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA214301
- Marketing category
- ANDA
- Marketing start
- 2022-03-17
- Substance
- LACOSAMIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LACOSAMIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LACOSAMIDE | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 563KS2PQY5 |
| Rxcui | 809974 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 25021-791-20 | LACOSAMIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | | 7 |
| 25021-791-20 | LACOSAMIDE | 20 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 20 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 25021-791 | LACOSAMIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 7 | Current NDC, Legacy NDC, 2 package rows | 20240711_6b4536d0-5703-42b0-9f59-46a3e1b75b22.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-791-20 | 25021079120 | 10 VIAL, GLASS in 1 CARTON (25021-791-20) / 20 mL in 1 VIAL, GLASS | 2022-03-17 | 0000-00-00 | No | No | Current |